Oral Abstract Session 01 - Global HIV Vaccine Enterprise

Tuesday, 11 September
AIDS Vaccine 2012
Program
12:00 – 12:15 rAd5 Prime/NYVAC-B Boost Regimen is Superior to NYVAC-B Prime/rAd5 OA9.07 LB
Boost Regimen for Both Response Rates and Magnitude of CD4 and CD8
T-cell Responses
P Bart, Y Huang, N Frahm, S Karuna, M Allen, NK Kochar, S Chappuis,
J Gaillard, B Graham, G Pantaleo
12:15 – 12:30 Phase 2a Safety and Immunogenicity Testing of DNA and Recombinant OA09.08 LB
Modified Vaccinia Ankara Virus Vaccines Expressing Virus-like Particles
P Goepfert, M Elizaga, D Montefiori, J Hural, S DeRosa, G Tomaras,
K Seaton, A Sato, L Ouedraogo, Y Donastorg, M Cardinali, J Lama,
L Baden, M Keefer, J McElrath, S Kalams, H Robinson
12:30 – 13:30 Lunch BCEC Level 2, Rooms 252 AB / 254 AB / 257 AB
12:30 – 13:30 Networking Lunch BCEC Level 2, Room 259 AB
Join us in BCEC Level 2, Room 259 AB where lunch tables have been reserved for young and
early-career investigators and community representatives to network with senior researchers.
13:30 – 14:45 Oral Abstract Session 10: BCEC Level 3,
HIV Transmission / Diversity
Chairs: Bette Korber and Zabrina Brumme
Room 258 ABC
13:30 – 13:45 Impact of Transmitted CTL Escape Mutations on Replicative Capacity and OA10.01
HIV Pathogenesis in Early Infection
J Prince, D Claiborne, D Heckerman, J Carlson, H Prentice, M Schaefer,
L Yue, J Mulenga, J Tang, P Goepfert, P Farmer, R Kaslow, S Allen, E Hunter
13:45 – 14:00 A Deeper View of Transmitted/Founder Viruses Using 454 Whole OA10.02
Genome Deep Sequencing
DC Tully, KA Power, H Bedard, CL Boutwell, P Charlebois, EM Ryan,
NJ Lennon, M Altfeld, MR Henn, TM Allen
14:00 – 14:15 Modeling Virus Exposure During Male to Female Transmission of HIV-1 OA10.03
A Carias, M McRaven, M Anderson, RS Veazey, TJ Hope
14:15 – 14:30 Beneficial HLA-mediated Viral Polymorphisms on the Transmitted Virus OA10.04
Additively Influence Disease Progression in HIV-1, Subtype C Infection
RS Ntale, DR Chopera, NK Ngandu, M Abrahams, A Debra, M Mlotswa,
L Werner, Z Woodman, K Mlisana, S Abdool Karim, CM Gray, C Williamson,
CAPRISA 002 AI Study Team
14:30 – 14:45 T-cell Based Sieve Analysis Ties HLA A*02 to Vaccine Efficacy and IgA-C1 OA10.05 LB
Immune Correlate in RV144 Thai Trial
T Hertz, A Gartland, H Janes, S Li, Y Fong, GD Tomaras, D Morris, D Geraghty,
GH Kijak, PT Edlefsen, M Rolland, BB Larsen, S Tovanabutra, E Sanders-Buell,
AC DeCamp, CA Magaret, H Ahmed, S Nariya, K Wong, H Zhao, W Deng,
BS Maust, M Bose, S Howell, M Lazzaro, A Bates, E Lei, A Bradfield,
G Ibitamuno, V Assawadarachai, RJ O’Connel, MS deSouza, S Nitayaphan,
S Rerks-Ngarm, ML Robb, MJ McElrath, BF Haynes, NL Michael, PB Gilbert,
JI Mullins, JH Kim
13
PROGRAM / TUESDAY